NCT06855641

Brief Summary

Substituting the administration of opioids with a combination of alternative analgesics, known as opioid-free anesthesia (OFA), is gaining in popularity today and is typically administered as part of a larger multimodal strategy. However, OFA adoption is not as common today as one could expect from the potential benefits of limiting opioid use and patient involvement in the decision may impact its adoption. Relevant shared decision-making process with patients concerning the use or limited use of opioids could improve patient autonomy and empowerment. There have been no studies that have evaluated patient preference regarding opioid use and its potential impact on the quality of recovery. The aim of this study is to compare the effect of patient preference on intraoperative opioid use on early postoperative quality of recovery following moderate risk laparoscopic/robotic abdominal surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 4, 2025

Completed
20 days until next milestone

Study Start

First participant enrolled

March 24, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 18, 2025

Completed
Last Updated

June 27, 2025

Status Verified

March 1, 2025

Enrollment Period

3 months

First QC Date

February 26, 2025

Last Update Submit

June 25, 2025

Conditions

Keywords

opioidsquality of recoveryanalgesiamoderate risk surgerypostoperative pain

Outcome Measures

Primary Outcomes (1)

  • Quality of recovery (QoR15)

    The primary outcome will be the comparison of early postoperative quality of recovery (QoR) on postoperative day 1 (POD#1) using the validated QoR-15 score (as a whole, and each item separately) between patients who choose vs don't choose their anesthesia strategies. The minimum score is 0 and the maximum score is 150. The higher score, the better quality of recovery

    Postoperative day 1

Secondary Outcomes (8)

  • Quality of Recovery at postoperative day 2

    Postoperative day 2

  • PONV incidence

    Postoperative day 2

  • Anesthesia satisfaction

    Postoperative day 1

  • Postoperative opioid consumption

    Postoperative 30

  • Intraoperative bradycardia

    during surgery

  • +3 more secondary outcomes

Study Arms (2)

Patient choose his analgesia type

EXPERIMENTAL

The patient here can decide which type of analgesia he/she wants ( OFA vs OBA)

Procedure: Opioid based AnesthesiaProcedure: opioid free anesthesia

Patient does not choose his analgesia strategy

ACTIVE COMPARATOR

If the patient does not choose his analgesia strategy, he/she will be randomized to OFA or OBA

Procedure: Opioid based AnesthesiaProcedure: opioid free anesthesia

Interventions

in this group, patient will receive standard of care at UCLA including fentanyl administration during surgery

Patient choose his analgesia typePatient does not choose his analgesia strategy

In this group, patients will not receive any opioids intraoperatively

Patient choose his analgesia typePatient does not choose his analgesia strategy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years.
  • Undergoing elective intermediate risk surgery under general anesthesia (robotic or laparoscopic assisted urological, gynecological or abdominal surgery).
  • American Society Anesthesiologists physical status classification system grades of I-IV.
  • English speaking.
  • Informed consent signed.

You may not qualify if:

  • Diagnosis of chronic pain
  • Preoperative prescribed opioids
  • Pregnancy or lactation.
  • History of mental disorders.
  • Contraindications to study drug (lidocaine, magnesium, dexmedetomidine, ketamine)
  • Patient is participating in another interventional trial
  • Patient is under judicial protection or is an adult under guardianship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ronald Reagan UCLA Medical Center

Los Angeles, California, 90095, United States

Location

UCLA Ronald Reagan medical center

Los Angeles, California, 90095, United States

Location

Related Publications (1)

  • Gricourt Y, Boulos NM, Delaporte A, Alexander B, Besada S, Bakhit R, Toukhtarian A, Neuman I, Pearce D, Nourian MM, Chebishian A, Zhou A, Boktor J, Mayanja D, Grogan T, Boldt D, Cannesson M, Forget P, Joosten A. Patient preference for intraoperative opioid use and early recovery after noncardiac surgery: protocol for a randomised factorial design trial of opioid-free versus opioid-based anaesthesia (the PERFECT trial). BJA Open. 2025 Jun 18;15:100420. doi: 10.1016/j.bjao.2025.100420. eCollection 2025 Sep.

MeSH Terms

Conditions

AgnosiaPain, Postoperative

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Study Officials

  • Alexandre JOOSTEN, MD PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
quality of recovery will be done by research coordinators and research students ( undergraduate students) not involved in patient care.
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: The PERFECT trial is an interventional, pragmatic, partially randomized trial with factorial design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 26, 2025

First Posted

March 4, 2025

Study Start

March 24, 2025

Primary Completion

June 18, 2025

Study Completion

June 18, 2025

Last Updated

June 27, 2025

Record last verified: 2025-03

Locations